Progress of human breast milk-derived exosomes in prevention and treatment of brochopulmonary dysplasia
10.3760/cma.j.issn.1673-4408.2022.01.013
- VernacularTitle:母乳来源外泌体防治支气管肺发育不良的研究进展
- Author:
Linjie LIU
1
;
Zhangbin YU
Author Information
1. 南京医科大学附属妇产医院（南京市妇幼保健院）儿科 210004
- Keywords:
Human breast milk;
Exosomes;
Bronchopulmonary dysplasia;
Premature infant
- From:
International Journal of Pediatrics
2022;49(1):58-62
- CountryChina
- Language:Chinese
-
Abstract:
Bronchopulmonary dysplasia(BPD)is a common chronic respiratory disease, with high mortality and poor long-term prognosis in surviving children, and there is currently no effective intervention.Breastfeeding reduces the incidence of BPD.These depend on a variety of bioactive substances in human breast milk, such as immunoglobulins, oligosaccharides, exosomes, etc.Exosomes are nano-like vesicle bodies secreted by cells, which participate in information transmission and functional regulation between cells.They have high affinity for the body and can tolerate digestion of gastrointestinal enzymes and stomach acid.These enable them to target lung, liver and other organs smoothly.They are expected to become a new method for the prevention and treatment of BPD.
